CoSolve

Finding bold and innovative solutions to transform patients' lives


CoSolve is a global, virtual, Open Innovation challenge at AstraZeneca, seeking to find new collaborators – those with the boldest innovations and solutions that can accelerate the creation of the next wave of medicines to help transform patients’ lives.

 


Helping us find real solutions for real challenges we face

At AstraZeneca, we know that however innovative our science, however effective our medicines and delivery, to achieve all we want to achieve, we cannot do it alone.

CoSolve is a bi-annual initiative that breaks down the traditional barriers to collaboration and to find ideas that are immediately translatable. Each challenge is about helping us accelerate our delivery to get the right treatments to the right patients.

We are looking for innovators, particularly from start-ups and early-stage biotechs, with the ability and freedom of operation to rapidly progress their idea into a full project in real time with support from AstraZeneca.




The Challenges

CoSolve submissions are now closed. Thank you to all of the submitters. We are judging the proposals, and will communicate the winners by June 2021. If you have any questions, please feel free to contact CrowdSourcing@astrazeneca.com.

New challenges will be announced every six months, so please sign up to our newsletter or keep checking back if your idea or innovation isn’t featured this time. 



How does CoSolve work?

CoSolve is all about speed. We are looking for solutions that can be put into practice in a 12-18 month timeframe. Selected partners will be innovators with the ability and freedom of operation to rapidly progress their idea into a full project with support from AstraZeneca. The key steps in the process are: